Throat Cancer Treatment Market Size, Industry Growth and Top Leaders
Throat cancer is a cancer of larynx, vocal chords and other
areas of the throat with common symptoms such as cough, sore throat, ear pain,
change in voice, difficulty swallowing and others. Market Research Future
(MRFR) has published a report stating that the Global Throat
Cancer Treatment Market is anticipated to grow at a significant rate during
the forecast period of 2020 to 2027.
Competitive Analysis:
The players in the global throat cancer market are
undergoing strategic alliances, mergers and acquisitions in order to expand
their business and dominate the global throat cancer market. The increased
research and development expenditure is strengthening the competition in the
global throat cancer market.
In August 2018, a study published in the British Medical
journal Open has confirmed that smoking tobacco significantly increases the
risk of oral HPV infection which leads to throat cancer.
The leading players profiled by MRFR in the report on the
global throat cancer market are Amgen Inc., Bristol-Myers Squibb, Celgene
Corporation, Eli Lilly and Company, Engeneic Ltd, F. Hoffmann-la Roche AG,
Merck & Co., Inc., Novartis, Pfizer Inc., Teva Pharmaceutical Industries
Ltd and Others.
Market Drivers and Restraints:
Increasing incidences of throat cancer that are majorly
caused due to the addictive habits of smoking, heavy alcohol consumption, betel
chewing and others are inducing demand for innovative medications and effective
treatments in the global throat cancer market, which in turn is fueling the
growth of the global throat cancer market. The rise in geriatric population and
widely spreading HPV infections are some other factors that are majorly driving
the global throat cancer market.
However, lack of proper diagnosis and targeted medication,
side effects related to chemotherapy drugs and lack of awareness in
underdeveloped regions are creating hindrance in the growth of the global
throat cancer market.
Market Segmentation:
The global throat cancer market has been segmented on the
basis of types and treatments. Based on types, the throat cancer market is
segmented into pharyngeal cancer and laryngeal cancer. Based on treatments, the
throat cancer market is segmented into surgery, radiation
for throat cancer, chemotherapy and others. Among these, the chemotherapy
segment is anticipated to account for the major share in the global throat
cancer market during the forecast period.
Regional Analysis:
Geographically, the global throat cancer market is segmented
into four major regions such as North America, Europe, Asia Pacific and the
Middle East and Africa. The North America region is anticipated to expand
significantly and project dominance over the global throat cancer market owing
to the presence of well-developed healthcare infrastructure, high health care
expenditure by the population and presence of prominent players in the global throat
cancer market in this region. The throat cancer market in the Europe region is
expanding at a noteworthy pace due to the increased research and development
activities in the healthcare sector of this region. The high prevalence of
throat cancer and increasing awareness regarding the symptoms and available
treatments are driving the throat cancer market in the developing economies of
the Asia pacific region.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to
unravel the complexity of various industries through our Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR
team have supreme objective to provide the optimum quality market research and
intelligence services to our clients.
Contact:
Market Research Future (part of Wantstats Research and Media
Private Limited),
99 Hudson Street,5Th Floor, New York, New York 10013,
United States of America
+1 646 845 9312
Comments
Post a Comment